Novanta Inc. NOVT
143.93
2.40
1.70%
as of 25 Sep
- Market cap
- $5.4B
- P/E
- 90.6×
Follow NOVT
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
68.13 | 80.95 | 84.36 | 102.04 |
P/S ratio |
3.75 | 4.44 | 4.75 | 6.46 | |
P/FCF ratio |
33.31 | 89.90 | 75.42 | 60.99 | |
P/Operating CF |
424.03 | 494.46 | 92.52 | 102.46 | |
P/B ratio |
4.49 | 3.31 | 3.64 | 4.12 | |
Price to Tangible BV |
0.00 | 8.96 | 9.60 | 8.17 | |
EV/Sales |
4.13 | 4.31 | 4.60 | 5.99 | |
EV/EBITDA |
25.56 | 27.08 | 30.51 | 40.06 | |
EV/Operating CF |
33.94 | 65.94 | 55.10 | 46.06 | |
EV/FCF |
36.66 | 87.21 | 73.09 | 56.51 | |
Quick Ratio |
1.44 | 2.71 | 2.59 | 3.70 | |
Current Ratio |
2.51 | 3.69 | 3.56 | 4.57 | |
Net Debt/EBITDA |
9.64 | (3.10) | (3.53) | (14.95) | |
Debt/Assets |
29.97% | 13.88% | 13.42% | 10.73% | |
Debt/Equity |
0.56 | 0.19 | 0.18 | 0.14 | |
Asset Turnover |
0.66 | 0.61 | 0.63 | 0.56 | |
Operating CF/Net income |
0.80 | 0.50 | 2.45 | 5.18 | |
Capex/Depreciation |
(0.27) | (0.54) | (0.27) | (0.51) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
9.72% | 8.85% | 9.02% | 9.02% | |
Selling, General and Administrative Expense of Revenue |
20.73% | 19.97% | 21.11% | 22.56% | |
Intangible Assets out of Total Assets |
0.56 | 0.46 | 0.45 | 0.37 | |
Share Based Compensation of Revenue |
2.70% | 3.19% | 3.80% | 3.70% | |
Graham Net Nets |
(0.07) | 0.07 | 0.06 | 0.09 | |
Graham Number |
27.15 | 34.47 | 31.96 | 37.55 | |
Earnings Yield |
1.47% | 1.24% | 1.19% | 0.98% | |
Free Cash Flow Yield |
3.00% | 1.11% | 1.33% | 1.64% | |
Revenue per Share |
6.89 | 7.06 | 6.37 | 6.48 | |
Operating CF per Share |
0.24 | 0.24 | 1.28 | 1.58 | |
Capex per Share |
(0.12) | (0.25) | (0.09) | (0.18) | |
Free Cash Flow per Share |
0.12 | (0.01) | 1.18 | 1.40 | |
Cash per Share |
2.48 | 10.41 | 9.62 | 17.52 | |
Shareholders Equity per Share |
22.28 | 35.92 | 32.43 | 39.42 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
22.28 | 35.92 | 32.43 | 39.42 | |
Free Cash Flow |
4.21 | (0.40) | 47.81 | 57.47 | |
Working Capital |
281.56 | 570.23 | 566.01 | 877.66 | |
Capital Expenditures |
(4.28) | (9.21) | (3.79) | (7.47) | |
Net Current Asset Value |
(235.92) | 289.78 | 298.78 | 600.43 | |
EV/EBIT |
41.34 | 44.93 | 51.92 | 66.80 | |
Capex to Sales |
0.02 | 0.04 | 0.01 | 0.03 | |
Net Profit Margin |
4.30% | 6.76% | 8.19% | 4.72% | |
Price to Operating Income |
37.57 | 46.31 | 53.57 | 72.10 | |
| Other line items | |||||
Average Receivables |
178.83 | 176.68 | 176.36 | 180.45 | |
Average Payables |
84.47 | 85.88 | 89.36 | 93.23 | |
Average Inventory |
167.00 | 166.45 | 169.29 | 180.39 | |
Average Assets |
1,462.32 | 1,597.81 | 1,592.26 | 1,825.32 | |
Average Common Equity |
771.84 | 1,029.99 | 1,040.39 | 1,208.95 |
Columns are period end dates